2007
DOI: 10.1016/j.jinorgbio.2007.06.025
|View full text |Cite
|
Sign up to set email alerts
|

Crystal structure based design of functional metal/protein hybrids

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
13
0
2

Year Published

2008
2008
2017
2017

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 18 publications
(15 citation statements)
references
References 60 publications
0
13
0
2
Order By: Relevance
“…Interactions between metal oxide NPs and proteins in vivo or in vitro involve coordination and non-covalent interactions [112]. Protein binding to ZnO NPs can result in major structural changes, unfolding behavior, of the periplasmic domain of the ToxR protein by a substantial decrease in the α-helical content of the free protein [98].…”
Section: Key Factors and Toxicity Mechanismsmentioning
confidence: 99%
“…Interactions between metal oxide NPs and proteins in vivo or in vitro involve coordination and non-covalent interactions [112]. Protein binding to ZnO NPs can result in major structural changes, unfolding behavior, of the periplasmic domain of the ToxR protein by a substantial decrease in the α-helical content of the free protein [98].…”
Section: Key Factors and Toxicity Mechanismsmentioning
confidence: 99%
“…22 Knowing all the iron-binding sites in ferritin–protein cages is important not only for understanding biological function but also for designing metal sites in ferritin–protein nanocages for nanodevices and nanocatalysts. 7,8,23 …”
Section: Introductionmentioning
confidence: 99%
“…Transition-metal complexes attached to biomolecules have, for example, been used as anticancer agents, [3,4] radioactive [4][5][6][7][8][9] or luminescent [10][11][12] labels, paramagnetic NMR probes, [13] or semisynthetic metalloenzymes in catalysis. [14][15][16][17][18][19][20][21][22][23][24][25][26][27][28] The incorporation of transition-metal complexes into proteins can be accomplished by a variety of different methods, Abstract: The first crystal structures of lipases that have been covalently modified through site-selective inhibition by different organometallic phosphonatepincer-metal complexes are described. Two ECE-pincer-type d 8 -metal complexes, that is, platinum (1) E= NMe 2 or SMe) were introduced prior to crystallization and have been shown to bind selectively to the Ser 120 residue in the active site of the lipase cutinase to give cut-1 (platinum) or cut-2 (palladium) hybrids.…”
Section: Introductionmentioning
confidence: 99%